AIN 2/3
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL (NCT05555862) | Frantz Viral Therapeutics, LLC | 2023-02-10 |
Track AIN 2/3 automatically
Every clearance here is in the API, with alerts when new ones post.